510(k) K162274
K162274 is an FDA 510(k) premarket notification submitted by Quidel Corporation for the device "Solana Strep Complete Assay". The FDA issued a decision of Substantially Equivalent on Oct 25, 2016. The device falls under product code PGX (Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System), a Class II device regulated under 21 CFR 866.2680. Quidel Corporation has 36 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 25, 2016
- Date Received
- Aug 12, 2016
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System
- Device Class
- Class II
- Regulation Number
- 866.2680
- Review Panel
- MI
- Submission Type
- 510(k)
An in vitro diagnostic test for the detection of Group A, C and G beta hemolytic Streptococcus in throat swab specimens from symptomatic patients.
Need the full FDA record for Quidel Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.